{"url_path":"/sec/krmd/8-k/2026-06-30/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 Entry into a Material Definitive Agreement**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/704440/0001161697-26-000139-index.html","accession_number":"0001161697-26-000139","cik":"0000704440","ticker":"KRMD","issuer_name":"KORU Medical Systems, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/704440/0001161697-26-000139-index.html","primary_entity_key":"0000704440","primary_entity_name":"KORU Medical Systems, Inc."},"word_count":400,"has_tables":true,"body_markdown":"**Item 1.01. Entry into a Material Definitive Agreement**\n\n \n\nOn June 24, 2026, KORU Medical Systems, Inc. (the\n“Company”) entered into that certain Amendment No. 1 to Amended and Restated Manufacturing and Supply Agreement (the “Amendment”)\nwith Command Medical Products, LLC (“Command”), which amends that certain Amended and Restated Manufacturing and Supply Agreement\ndated January 1, 2024 between the Company and Command (the “Agreement”). Under the Agreement, Command manufactures and supplies\nthe Company’s subassemblies, needle sets and tubing products pursuant to the Company’s specifications and purchase orders\n(the “Products”). The Amendment amends certain provisions of the Agreement for purposes of, among other things, (i) extending\nthe initial term of the Agreement, (ii) modifying various pricing and payment terms, including Product pricing, annual price adjustments\nand application of pass-through cost savings, (iii) establishing each party’s rights and obligations with respect to a second manufacturing\nsite, including the obligation for Command to obtain and qualify such second manufacturing site by December 31, 2027 and the Company’s\nright to terminate the Agreement in the event Command fails to do the same (subject to a thirty (30) day cure period), (iv) establishing\nCommand as the exclusive manufacturer of a limited set of Products, (v) broadening the applicability of the wind-up period rights and\nobligations, (vi) clarifying the intellectual property ownership between the parties and the corresponding intellectual property licenses\ngranted under the Agreement; (vii) making the assignment rights mutual, and (viii) removing the non-competition provision.\n\n \n\nThe initial term of the Agreement now expires by its\nterms on December 31, 2031, however the term of the Agreement will still automatically renew for successive one-year periods unless one\nparty elects not to renew by providing the other party with at least one hundred and eighty (180) days prior notice of its intent not\nto renew the Agreement.  Each party’s termination rights remain unchanged, where either party may terminate the Agreement (i)\nupon a material breach by the other Party that has not been cured within 45 days, (ii) upon the bankruptcy or insolvency of the other\nparty, (iii) in the event of force majeure continuing for at least thirty (30) days, or (iv) as otherwise expressly set forth in the Agreement.\nThe Amendment provides the Company an additional right to terminate the Agreement in the event Command fails to satisfy the requirements\nfor the second manufacturing site and does not cure such failure within thirty (30) days."}